TRAF6 promotes chemoresistance to paclitaxel of triple negative breast cancer via regulating PKM2-mediated glycolysis
Authors:
Preprint
- 16 January 2023
- preprint
- Published by Springer Nature in Research Square
Abstract
Ample evidence reveals that glycolysis plays an important role in cancer progression; however, the underlying mechanism of its drug resistance is still worth being further explored. TRAF6, a E3 ubiquitin ligase, is well known to overexpress in various types of cancers, which predicts poor prognosis. In our study, we discovered that TRAF6 expressed more significantly in triple negative breast cancer (TNBC) than in other subtypes of breast cancers, promoting chemoresistance to paclitaxel; that the inhibited TRAF6 expression in the chemoresistant TNBC (TNBC-CR) cells enhanced the sensitivity by decreasing glucose uptake and lactate production; that TRAF6 regulated glycolysis and facilitated chemoresistance via binding directly to PKM2; and that overexpressing PKM2 in the TNBC-CR cells with TRAF6 knocked down regained significantly TRAF6-dependent drug resistance and glycolysis. Additionally, we verified that TRAF6 could facilitate PKM2-mediated glycolysis and chemoresistance in the animal models and clinical tumor tissues. Thus, we identified the novel function of TRAF6 to promote glycolysis and chemoresistance in TNBC by regulating PKM2, which could provide a potential therapeutic target for TNBC treatment.Keywords
All Related Versions
- Version 1, 2023-01-16, Research Square
- Published version: Cancer Medicine, 12 (19), 19807.
This publication has 43 references indexed in Scilit:
- A Review of Applications of Metabolomics in CancerMetabolites, 2013
- Pyruvate kinase M2-specific siRNA induces apoptosis and tumor regressionJournal of Experimental Medicine, 2012
- Intracellular ATP Levels Are a Pivotal Determinant of Chemoresistance in Colon Cancer CellsCancer Research, 2012
- The Warburg effect in 2012Current Opinion in Oncology, 2012
- Aerobic Glycolysis: Meeting the Metabolic Requirements of Cell ProliferationAnnual Review of Cell and Developmental Biology, 2011
- The role of pattern-recognition receptors in innate immunity: update on Toll-like receptorsNature Immunology, 2010
- The E3 Ligase TRAF6 Regulates Akt Ubiquitination and ActivationScience, 2009
- Signal integration by JNK and p38 MAPK pathways in cancer developmentNature Reviews Cancer, 2009
- Isotype‐specific inhibitors of the glycolytic key regulator pyruvate kinase subtype M2 moderately decelerate tumor cell proliferationInternational Journal of Cancer, 2008
- Brick by brick: metabolism and tumor cell growthCurrent Opinion in Genetics & Development, 2008